Occupe actuellement un poste chez Apellis Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Independent Director | Apellis Pharmaceuticals Inc | 1 mars 2010 - |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2024-03-20 | 2024-03-19 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
18 681
-9.7%
57,181 068 161 USD |
18 681 -9.7% | 57,18 | 1 068 161 USD | |
2023-11-21 | 2023-11-17 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
8 894
-6.8%
49,99444 620 USD |
8 894 -6.8% | 49,99 | 444 620 USD | |
2023-11-21 | 2023-10-17 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
24 000
-10.0%
49,001 176 000 USD |
24 000 -10.0% | 49,00 | 1 176 000 USD | |
2023-03-02 | 2023-03-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
500
-0.4%
65,3332 665 USD |
500 -0.4% | 65,33 | 32 665 USD | |
2023-02-02 | 2023-02-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
500
-0.4%
52,6126 305 USD |
500 -0.4% | 52,61 | 26 305 USD | |
2023-01-05 | 2023-01-03 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
500
-0.4%
50,7025 350 USD |
500 -0.4% | 50,70 | 25 350 USD | |
2022-12-02 | 2022-12-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
500
-0.4%
49,9324 965 USD |
500 -0.4% | 49,93 | 24 965 USD | |
2022-11-03 | 2022-11-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
500
-0.4%
60,8330 415 USD |
500 -0.4% | 60,83 | 30 415 USD | |
2022-09-08 | 2022-09-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
15 000
-5.9%
65,00975 000 USD |
15 000 -5.9% | 65,00 | 975 000 USD | |
2022-08-12 | 2022-08-11 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
30 000
-10.5%
65,631 968 900 USD |
30 000 -10.5% | 65,63 | 1 968 900 USD | |
2022-06-24 | 2022-06-23 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
15 000
-5.0%
45,00675 000 USD |
15 000 -5.0% | 45,00 | 675 000 USD | |
2021-05-20 | 2021-05-20 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
5 773
-15.3%
48,10277 681 USD |
5 773 -15.3% | 48,10 | 277 681 USD | |
2021-05-20 | 2021-05-19 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
7 612
-2.5%
50,00380 600 USD |
7 612 -2.5% | 50,00 | 380 600 USD | |
2021-05-20 | 2021-05-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
800
-0.3%
54,0243 216 USD |
800 -0.3% | 54,02 | 43 216 USD | |
2021-05-20 | 2021-05-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
10 388
-3.3%
53,50555 758 USD |
10 388 -3.3% | 53,50 | 555 758 USD | |
2021-05-20 | 2021-05-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
1 200
-0.4%
52,0162 412 USD |
1 200 -0.4% | 52,01 | 62 412 USD | |
2021-05-20 | 2021-05-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
22 318
-37.2%
54,571 217 893 USD |
22 318 -37.2% | 54,57 | 1 217 893 USD | |
2021-05-20 | 2021-05-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
36 387
-37.8%
53,781 956 893 USD |
36 387 -37.8% | 53,78 | 1 956 893 USD | |
2021-05-20 | 2021-05-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
14 216
-12.9%
52,63748 188 USD |
14 216 -12.9% | 52,63 | 748 188 USD | |
2021-05-20 | 2021-05-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
64 179
-36.7%
51,663 315 487 USD |
64 179 -36.7% | 51,66 | 3 315 487 USD | |
2020-12-15 | 2020-12-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
214
-0.1%
56,2512 038 USD |
214 -0.1% | 56,25 | 12 038 USD | |
2020-12-15 | 2020-12-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
17 132
-8.9%
55,01942 431 USD |
17 132 -8.9% | 55,01 | 942 431 USD | |
2020-12-15 | 2020-12-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
7 654
-3.8%
53,86412 244 USD |
7 654 -3.8% | 53,86 | 412 244 USD | |
2020-12-07 | 2020-12-07 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
9 470
-4.5%
51,00482 970 USD |
9 470 -4.5% | 51,00 | 482 970 USD | |
2020-12-07 | 2020-12-07 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
9 094
-4.2%
50,41458 429 USD |
9 094 -4.2% | 50,41 | 458 429 USD | |
2020-12-07 | 2020-12-04 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
1 384
-0.6%
51,0570 653 USD |
1 384 -0.6% | 51,05 | 70 653 USD | |
2020-12-07 | 2020-12-04 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
5 052
-2.2%
50,04252 802 USD |
5 052 -2.2% | 50,04 | 252 802 USD |